NCT03148002View on ClinicalTrials.gov

Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

April 1, 2018

Study Completion Date

June 5, 2018

Conditions
ConstipationPeritoneal Dialysis Complication
Interventions
DRUG

Current Bowel Protocol (senna/lactulose)

Stimulant and Osmotic Laxatives.

DRUG

PEG Bowel Protocol (PEG/lactulose)

Osmotic Laxatives.

Trial Locations (1)

B3H 2Y9

Queen Elizabeth Health Sciences Centre, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT03148002 - Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation | Biotech Hunter | Biotech Hunter